In this collaborative case study presentation, industry experts will discuss the latest innovations in rapid microbiological methods for environmental monitoring within the aseptic filling of cell and gene therapy drug products. Case studies highlighting the efficiency and the qualification of biofluorescent particle counters (BFPCs) in gloveless, robotic, aseptic filling isolators will be presented.
Attendees will learn the impact of new and ever-changing industry regulations surrounding aseptic filling, and best practices for adherence to regulations and adoption of new methods designed to ensure the highest drug product quality, safety, and efficiency. Learn how quality by design (QbD) principles can remove human interventions and indirect contact surfaces, minimize sources of particle generation, and more.